Table 1.
Measures | Outcomes | Timeframe | Hypothesis or question | |
Primary outcome |
|
|
|
|
|
Bodyweight scale | Change in body mass (in kilograms) | 12 weeks | Those in the Keyto intervention arm will achieve greater weight loss at 12 weeks than those in the Weight Watchers arm. |
Secondary outcome |
|
|
|
|
|
Bodyweight scale |
|
|
|
|
|
Change in body mass (in kilograms) |
24 and 48 weeks | Those in the Keyto intervention arm will achieve greater weight loss at 24 and 48 weeks than those in the Weight Watchers arm. |
|
|
Change in body mass (in kilograms) |
Daily weight measured during the first 12 weeks | What are the patterns of body mass change during the first 12 weeks between the 2 study groups? |
|
Automated self-administered 24-hour dietary recall |
|
|
|
|
|
Carbohydrate intake in 24-hour period (in grams) |
12, 24, and 48 weeks | Those in the Keyto intervention arm will report lower carbohydrate intake at 12, 24, and 48 weeks. |
|
|
Total fat, saturated fat, polyunsaturated fat, monounsaturated fat intake in 24-hour period (in grams) | 12, 24, and 48 weeks | Does the Keyto intervention or WW app intervention influence fat intake from baseline to 12, 24, and 48 weeks? |
|
|
Total energy intake in 24-hour period (in kilocalories) |
12, 24, and 48 weeks |
We will examine changes from baseline to 12, 24, and 48 weeks in total energy intake in the Keyto and Weight Watchers groups. |
|
Venous blood sample | HbA1ca, fasting glucose, fasting insulin, fasting high-sensitivity C-reactive protein, fasting HOMA-IRb, fasting total cholesterol, fasting HDLc cholesterol, fasting lipoprotein fractions, fasting lipoprotein (a), fasting triglycerides, fasting non-HDL cholesterol | 12 and 48 weeks | We will examine changes from baseline to 12 and 48 weeks in metabolic and cardiovascular risk blood biomarkers in the Keyto and Weight Watchers groups. |
Exploratory outcome |
|
|
|
|
|
Venous blood sample | Fasting albumin, fasting globulin, fasting total bilirubin, fasting alkaline phosphatase, fasting aspartate aminotransferase, fasting alanine aminotransferase | 12 and 48 weeks | We will explore changes from baseline to 12 and 48 weeks in blood biochemistry in the Keyto and Weight Watchers group. |
Manipulation checks |
|
|
|
|
|
Questionnaires |
|
|
|
|
|
Food attitude survey | 12, 24, and 48 weeks | We will examine all baseline questionnaires as potential covariates. We will also examine differences in questionnaire measures between the 2 groups at 12, 24, and 48 weeks. |
|
|
Cravings, mood, and energy | Weekly | |
|
|
Self-reported dietary adherence | Weekly | |
|
|
Pittsburgh Sleep Quality Index | 12, 24, and 48 weeks |
aHbA1c: hemoglobin A1c.
bHOMA-IR: homeostasis model assessment of insulin resistance.
cHDL: high-density lipoprotein.